$LLY INSIGHTS →Eli Lilly expanded its R&D pipeline by entering a new research collaboration with Abbisko, reinforcing its strategy of partnering externally to develop future therapies.
Read the full research in the app
A subscription is required to access the full thread.
Open in the app →